Experience in Using Antiviral Agents for the Treatment of Novel Coronavirus Infection (COVID-19) in Kyrgyzstan

Experience in Using Antiviral Agents for the Treatment of Novel Coronavirus Infection (COVID-19) in Kyrgyzstan

The national clinical guidelines for the treatment of novel coronavirus infection (COVID-19) are the main source of information and the reference point for clinical decision-making by healthcare professionals in the Kyrgyz Republic. The recommendations presented in these documents are largely based...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Zurdinova, A. Z. Kutmanova
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2021-12-01
Series:Безопасность и риск фармакотерапии
Subjects:
coronavirus infection
covid-19
clinical guideline
lopinavir+ritonavir
adverse drugs reactions
Online Access:https://www.risksafety.ru/jour/article/view/250
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items